Skip to content
healthcare.dev

encer

NDC 82509-001, Cadmium sulphuratum, Carbo animalis, Phosphoricum acidum, Radium bromatum, X-ray, tablet, orally disintegrating, from B'OKCARES LTD.

Product NDC
82509-001
Status
Listed
Labeler
B'OKCARES LTD
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82509-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CADMIUM SULFIDE30 [hp_C]/1
  • CARBO ANIMALIS30 [hp_C]/1
  • PHOSPHORIC ACID30 [hp_C]/1
  • RADIUM BROMIDE30 [hp_C]/1
  • ALCOHOL, X-RAY EXPOSED (1000 RAD)6 [hp_C]/1
Package NDCNDC-11Package
82509-001-60825090001603 BLISTER PACK in 1 CARTON (82509-001-60) / 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82509-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82509-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82509-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.